• Opinion
• [Reporter's View] Super precision medicine
• by Eo, Yun-Ho Oct 30, 2024 05:53am

• Opinion
• [Reporter’s View] Deadlines are set for a reason
• by Eo, Yun-Ho Oct 17, 2024 05:51am

• Opinion
• [Reporter's view] Expanding NIP to include 9-vHPV
• by Whang, byung-woo Oct 16, 2024 05:50am

• Opinion
• [Reporter's view] Creating a virtuous cycle for K-bio growth
• by Son, Hyung Min Oct 11, 2024 05:54am

• Opinion
• [Reporter's View]Industry expectations rise with new changes
• by Eo, Yun-Ho Oct 10, 2024 05:50am

• Opinion
• [Reporter’s View]Contradictions in the CSO reporting system
• by Kim, Jin-Gu Oct 7, 2024 05:48am

• Opinion
• [Reporter’s View] How to increase the new drug approval fee
• by Whang, byung-woo Sep 26, 2024 05:51am

• Opinion
• [Reporter’s View] The new drug approval fee hike
• by Lee, Hye-Kyung Sep 19, 2024 05:48am

• Opinion
• [Reporter’s View] Benefits of the U.S. Biosecure Act
• by Son, Hyung Min Sep 13, 2024 05:50am

• Opinion
• [Reporter's View] ‘Tyranny of Drug Committees persist'
• by Eo, Yun-Ho Sep 11, 2024 05:54am